KD-357 Phase III Study
Phase 3
- Conditions
- preexposure prophylaxis against rabies
- Registration Number
- JPRN-jRCT2080222145
- Lead Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
(1)Subjects who are healthy Japanese between 20 and 65 inclusive at the time of obtaining informed consent.
(2)Subjects who are able to give written informed consent.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rabies virus neutralizing antibody seropositive rate
- Secondary Outcome Measures
Name Time Method